Technology
Pipelines
Research Centers
Reseach Alliance
Business Development
Hanmi's Global Presence
Manufacturing Facilities
Products
Contact us
CEO's message
Stock Information
Financial Reports
Presentations
IR Contact
Latest News
News Archives
Company Profile
Leadership&Management
History
Affiliates
Career Opportunities
Home
> Press Center >
Latest News
2010
2009
2008
Jul. 2010
[
2
News]
14
Amosartan Produces Good Newses
29, Jul. 2010
13
Amosartan, The 1st approval as the initial therapy among CCB+ARB hypertension Combo Drugs
08, Jul. 2010
May. 2010
[
2
News]
12
Phase 1 underway for Atorvastatin plus Aspirin fixed dose combination drug
19, May. 2010
11
Hanmi pharmaceuticals to be exempted from drug price cut for 5 years
12, May. 2010
Apr. 2010
[
4
News]
10
Nikkei reports the presentation of Hanmi at a JPLA meeting
30, Apr. 2010
9
LAPSCOVERY Platform Technology obtains US Patents
29, Apr. 2010
8
Hanmi submits IMPD in Europe for phase I clinical trials of LAPS-Exendin
27, Apr. 2010
7
Beijing Hanmi, High-tech Industry Certification
08, Apr. 2010
Mar. 2010
[
2
News]
6
Most Prescribed Hypertension combo drug in Korea?
25, Mar. 2010
5
Hanmi wins the best drug research award of KDRA
04, Mar. 2010
Feb. 2010
[
3
News]
4
Hanmi's Amosartan ranked the highest for detailing drugs
22, Feb. 2010
3
Hanmi to make Medicine Donation for Haiti
05, Feb. 2010
2
IND Application for long-acting Human Growth Hormone Approved
01, Feb. 2010
Jan. 2010
[
1
News]
1
KFDA Approves IND Application of Once Monthly Exendin4 analog
12, Jan. 2010
+++Family Site+++
Hanmi Fine Chemical Co., Ltd
Beijing Hanmi Pharmaceutical Co., Ltd
Hanmi FT Co., Ltd
Hanmi IT Co., Ltd
Hanmi Medicare Co., Ltd
